Effectdossier · gearchiveerd kwartaal
ERAS
Erasca, Inc. · Healthcare · Biotechnology
16Gevolgde houders
+1Δ houders
49.01MGehouden aandelen
$106.84MGerapporteerde waarde
+1Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +6.7% ·
aandelenstroom -4.1% ·
netto nieuwe posities +6.2%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +13 | 109.93M | $2.01B | +17 | −4 |
| Q1 2026 | 87 | +18 | 99.27M | $1.57B | +25 | −7 |
| Q4 2025 | 69 | +1 | 63.96M | $237.91M | +1 | — |
| Q3 2025 | 16 | +1 | 49.01M | $106.84M | +1 | — |
| Q2 2025 | 12 | -3 | 45.80M | $58.17M | — | −3 |
| Q1 2025 | 12 | 0 | 17.13M | $23.47M | +1 | −1 |
| Q4 2024 | 12 | 0 | 25.73M | $64.58M | +1 | −1 |
| Q3 2024 | 11 | 0 | 18.60M | $50.78M | — | — |
| Q2 2024 | 11 | — | 15.91M | $37.56M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 15.07M | -0.6% | $32.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (passief) | 12.81M | +0.9% | $27.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passief) | 12.81M | +0.9% | $27.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 12.81M | +0.9% | $27.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 4.85M | +0.3% | $10.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 4.85M | +0.3% | $10.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (passief) | 4.03M | +0.7% | $8.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 2.91M | -23.2% | $6.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 2.54M | — | $5.53M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Goldman Sachs Group ✦ | 2.52M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Goldman Sachs Group ✦ | 2.52M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Goldman Sachs Group ✦ | 2.52M | — | $5.49M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 1.02M | +36.7% | $2.21M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 664.34K | -6.2% | $1.45M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 31 | Wellington Management ✦ | 600.58K | -32.2% | $1.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 32 | Wellington Management ✦ | 600.58K | -32.2% | $1.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | Wellington Management ✦ | 600.58K | -32.2% | $1.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | Marshall Wace ✦ | 526.01K | -74.6% | $1.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 419.55K | +11.3% | $914,628 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 419.55K | +11.3% | $914,628 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | Two Sigma Investments ✦ | 347.77K | -18.7% | $758,132 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 341.80K | Nieuw | $745,122 | 0.0% | New | 1 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 341.80K | Nieuw | $745,122 | 0.0% | New | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Morgan Stanley ✦ | 268.67K | — | $585,701 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | T. Rowe Price ✦ | 93.58K | +8.2% | $205,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Citadel Advisors | $745,122 | 0.0% |
| Citadel Advisors | $745,122 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 223 houders, 272.55M aandelen, $4.00B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API